home / stock / crmd / crmd quote
Last: | $11.72 |
---|---|
Change Percent: | 31.69% |
Open: | $9.76 |
Close: | $11.72 |
High: | $12.78 |
Low: | $9.2517 |
Volume: | 4,411,468 |
Last Trade Date Time: | 02/02/2021 04:57:37 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$11.72 | $9.76 | $11.72 | $12.78 | $9.2517 | 4,411,468 | 02-02-2021 |
$8.9 | $9 | $8.9 | $9.68 | $8.5 | 1,444,447 | 02-01-2021 |
$8.75 | $8.75 | $8.75 | $9.04 | $8.6205 | 438,976 | 01-29-2021 |
$8.74 | $8.85 | $8.74 | $9.05 | $8.65 | 457,758 | 01-28-2021 |
$8.76 | $8.7 | $8.76 | $9.0878 | $8.5853 | 476,408 | 01-27-2021 |
$8.9 | $8.6 | $8.9 | $9.2062 | $8.54 | 647,807 | 01-26-2021 |
$8.51 | $8.75 | $8.51 | $8.84 | $8.385 | 598,661 | 01-25-2021 |
$8.64 | $8.52 | $8.64 | $8.67 | $8.39 | 636,529 | 01-22-2021 |
$8.63 | $8.86 | $8.63 | $8.9 | $8.6 | 417,728 | 01-21-2021 |
$8.84 | $9 | $8.84 | $9 | $8.59 | 380,835 | 01-20-2021 |
$8.99 | $8.92 | $8.99 | $9 | $8.65 | 358,635 | 01-19-2021 |
$8.84 | $8.79 | $8.84 | $9.09 | $8.74 | 282,302 | 01-18-2021 |
$8.84 | $8.79 | $8.84 | $9.09 | $8.74 | 282,210 | 01-15-2021 |
$8.9 | $8.88 | $8.9 | $9.08 | $8.81 | 579,793 | 01-14-2021 |
$8.74 | $8.87 | $8.74 | $8.9 | $8.58 | 188,659 | 01-13-2021 |
$8.75 | $8.32 | $8.75 | $8.77 | $8.29 | 342,319 | 01-12-2021 |
$8.32 | $8.79 | $8.32 | $8.85 | $8.17 | 544,995 | 01-11-2021 |
$8.78 | $8.18 | $8.78 | $8.84 | $8.12 | 1,202,612 | 01-08-2021 |
$8.14 | $7.92 | $8.14 | $8.22 | $7.92 | 211,245 | 01-07-2021 |
$7.94 | $7.77 | $7.94 | $8.05 | $7.6 | 286,479 | 01-06-2021 |
News, Short Squeeze, Breakout and More Instantly...
BERKELEY HEIGHTS, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that the Center for Medicare & Medicaid Service...
BERKELEY HEIGHTS, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced DefenCath® (taurolidine and heparin) catheter ...
BERKELEY HEIGHTS, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing therap...